Moderna
MRNA
490 hedge funds and large institutions have $14.1B invested in Moderna in 2020 Q2 according to their latest regulatory filings, with 243 funds opening new positions, 136 increasing their positions, 88 reducing their positions, and 52 closing their positions.
367% more first-time investments, than exits
New positions opened: 243 | Existing positions closed: 52
140% more capital invested
Capital invested by funds: $5.87B → $14.1B (+$8.21B)
63% more funds holding
Funds holding: 300 → 490 (+190)
55% more repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 88
43% more funds holding in top 10
Funds holding in top 10: 7 → 10 (+3)
6% more call options, than puts
Call options by funds: $494M | Put options by funds: $468M
3.14% less ownership
Funds ownership: 59.52% → 56.39% (-3.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$699M |
| 2 |
BlackRock
New York
|
+$408M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$276M |
| 4 |
Jane Street
New York
|
+$63.1M |
| 5 |
Goldman Sachs
New York
|
+$59.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$602M |
| 2 |
AG
Artal Group
Luxembourg
|
-$137M |
| 3 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$82.4M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$72.7M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$63.4M |
MRNA Hedge Fund Activity: Q2 2020 in Review
490 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q2 2020, worth a combined $14.1B — up 140% from $5.87B a quarter earlier.
Buyers outnumbered sellers: 243 funds opened new MRNA positions and 52 closed out — a net gain of 191 holders — while 136 added to existing stakes and 88 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $699M. The largest seller was Flagship Pioneering, cutting an estimated $602M.
- 490 institutional investors held Moderna (MRNA) as of Q2 2020, up from 300 in Q1 2020.
- Funds reported $14.1B of Moderna stock for Q2 2020, up 140% quarter-over-quarter.
- 243 funds opened new Moderna positions in Q2 2020 and 52 closed out, a net change of +191 holders.
- The largest Moderna buyer in Q2 2020 was Fidelity Investments, an estimated $699M added.
- The largest Moderna seller in Q2 2020 was Flagship Pioneering, an estimated $602M sold.
Based on aggregated 13F filings for Q2 2020.